Media Invitation – IJCAI 2025, Montréal, Canada
Artificial Intelligence for a Better World – Since 1969

The 34th International Joint Conference on Artificial Intelligence (IJCAI) takes place August 16–22, 2025 in Montréal, Canada, bringing together over 2,000 AI researchers, practitioners, and thought leaders. Guided by the theme “AI at the service of society”, IJCAI 2025 features world-class keynote speakers, award-winning researchers, thematic tracks on AI for Social Good, Human-Centred AI, and AI, Arts & Creativity, as well as admission free public events like the AI Lounge: Between Wonder and Caution.

Highlights include talks by Yoshua Bengio, Heng Ji, Luc De Raedt, Bernhard Schölkopf, and IJCAI 2025 awardees Aditya Grover, Rina Dechter, and Cynthia Rudin. The program also showcases AI-driven competitions, an AI Art Gallery, and discussions on ethics, creativity, and global impact.

Full program & details: https://2025.ijcai.org
Media contact: mrozman@ijcai.org

Neurons in the gut produce a molecule that plays a pivotal role in shaping the gut’s immune response during and after inflammation, according to a new study by Weill Cornell Medicine investigators. The findings suggest that targeting these neurons and the molecules they produce could open the door to new treatments for inflammatory bowel disease and other disorders driven by gut inflammation.

The Okinawa Institute of Science and Technology (OIST) Associate Professor Paola Laurino has been selected as one of the top 10 global awardees in the Life Sciences category of the Falling Walls Science Breakthrough, presented by Germany’s Falling Walls Foundation.  

Extracellular vesicles (EVs) are tiny particles released by cells that help control egg development. In a recent review, researchers from China explored how EVs influence oocyte health by transferring important molecules between cells. The article discusses how EV function changes under disease conditions and how this affects fertility. It also highlights the growing potential of therapeutic EVs to improve egg quality and treat ovarian disorders, offering new possibilities for advancing reproductive medicine.

A landmark mini-review from Peking Union Medical College Hospital delivers a snapshot of nine PD-1/IL-2 bi-functional drugs now in clinical trials. By silencing PD-1 and selectively fueling T cells with refined IL-2 in one molecule, these agents reinvigorate exhausted immune soldiers while sparing healthy tissue, promising safer and broader cancer cures.

How did life leap from simple microbial cells to the complex, structured cells that make up animals, plants, and fungi? A new study in The EMBO Journal by researchers at the Indian Institute of Science (IISc) offers fresh insight into this deep evolutionary mystery. It sheds light on how the cytoskeleton, the cell’s internal scaffold, may have evolved from far simpler beginnings in ancient microbes.